Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study
暂无分享,去创建一个
M. Landray | D. Wheeler | J. Emberson | C. Baigent | L. Blackwell | J. Townend | T. Dasgupta | C. Ferro | M. Morgan | R. Zakeri | E. Lamb | R. Dalton | D. Nair | S. Vickery | P. Ayrton
[1] C. McCulloch,et al. Risk factors for end-stage renal disease: 25-year follow-up. , 2009, Archives of internal medicine.
[2] C. Price,et al. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] R. Glynn,et al. Predicting outcomes in CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] O. Djurdjev,et al. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] David H. Smith,et al. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[6] B. Brenner,et al. Renal risk scores: progress and prospects. , 2008, Kidney international.
[7] Anders Larsson,et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.
[8] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[9] J. Kaufman,et al. Age affects outcomes in chronic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.
[10] M. Landray,et al. Cross-Sectional Analysis of Abnormalities of Mineral Homeostasis, Vitamin D and Parathyroid Hormone in a Cohort of Pre-Dialysis Patients , 2007, Nephron Clinical Practice.
[11] M. Landray,et al. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Misleading Associations between Cholesterol and Vascular Outcomes in Dialysis Patients: The Need for Randomized Trials , 2007, Seminars in dialysis.
[12] J. Griffith,et al. The Framingham predictive instrument in chronic kidney disease. , 2007, Journal of the American College of Cardiology.
[13] S de Lusignan,et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. , 2007, Kidney international.
[14] D. Kent,et al. Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.
[15] T. Hansen,et al. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. , 2007, European heart journal.
[16] R. Collins,et al. N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. , 2007, Journal of the American College of Cardiology.
[17] F. Dekker,et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey , 2006, BMJ : British Medical Journal.
[18] A. Tamakoshi,et al. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] Zhongxin Zhang,et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[20] A. Garg,et al. Chronic kidney disease and mortality risk: a systematic review. , 2006, Journal of the American Society of Nephrology : JASN.
[21] G. Francis,et al. Cardiac troponins and chronic kidney disease. , 2006, Kidney international.
[22] C. Price,et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] A. Dobson,et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review , 2005, BMJ : British Medical Journal.
[24] A. Murray,et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.
[25] C. Herzog,et al. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. , 2004, Clinical chemistry.
[26] C. Gullion,et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. , 2004, Archives of internal medicine.
[27] M. Landray,et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[28] R. Foley,et al. Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: a 2 year prospective study. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] P. Stenvinkel,et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality , 2003, Journal of internal medicine.
[30] Fred S Apple,et al. Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease , 2002, Circulation.
[31] D C Wheeler,et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] David Roth,et al. A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .
[33] Colin Baigent,et al. Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.
[34] M. Landray,et al. Abnormalities of endothelial function in patients with predialysis renal failure , 2000, Heart.
[35] D. Collett. Modelling Survival Data in Medical Research , 1994 .
[36] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[37] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[38] R. Peto. THE HORSE-RACING EFFECT , 1981, The Lancet.
[39] B. Astor,et al. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[40] David C. Murray,et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.